Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1Lymphoid 1Classical hematology 1

Conditions

Leukemia, Myeloid, Acute 112Leukemia, Lymphocytic, Chronic, B-Cell 111Leukemia 102Myelodysplastic Syndromes 101Precursor Cell Lymphoblastic Leukemia-Lymphoma 80Lymphoma 77Lymphoma, Non-Hodgkin 73Multiple Myeloma 69Hodgkin Disease 67Lymphoma, Follicular 55Lymphoma, Mantle-Cell 52Leukemia, Myelogenous, Chronic, BCR-ABL Positive 51Myeloproliferative Disorders 50Congenital Abnormalities 47Lymphoma, Large B-Cell, Diffuse 46Lymphoma, B-Cell, Marginal Zone 45Leukemia, Myeloid, Accelerated Phase 43Leukemia, Myeloid, Chronic-Phase 42Burkitt Lymphoma 41Leukemia, Myelomonocytic, Chronic 40Blast Crisis 33Primary Myelofibrosis 32Lymphoma, Large-Cell, Immunoblastic 30Waldenstrom Macroglobulinemia 29Neoplasms, Plasma Cell 29Melanoma 29Anemia, Refractory, with Excess of Blasts 29Recurrence 27Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 25Myelodysplastic-Myeloproliferative Diseases 24

Interventions

fludarabine phosphate 1fludarabine 1Mycophenolic Acid 1Cyclosporins 1Clofarabine 1Busulfan 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Hemoglobinopathies × fludarabine phosphate × Clear all
NCT04644016 2026-03-13

Cord Blood Transplant in Children and Young Adults With Blood Cancers and Non-malignant Disorders

Memorial Sloan Kettering Cancer Center

Phase 2 Recruiting
31 enrolled
Classical hematologyLymphoidMyeloidOther hematologic neoplasm

Bone Marrow Failure Disorders, Anemia, Refractory, with Excess of Blasts, Hemoglobinopathies, Lymphoma, Non-Hodgkin, Myeloproliferative Disorders, Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡